• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Anti-Fungal Drugs Market 2021-2027: trends, Industry Top Leaders, Comprehensive Analysis, Devices Type, Regional Segments

July 14th, 2021 Fortune Business Insights Releases

Anti-Fungal Drugs Market | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Fungal Drugs Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Fungal Drugs Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Fungal Drugs is to hit USD 13.17 billion value by 2027 at CAGR of 3.3%. Report segments Anti-Fungal Drugs Market By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2020-2027

Major Anti-Fungal Drugs manufacturers are studied in this report for better understanding of global market scenario:

  • Merck & Co., Inc.
  • Leadiant Biosciences, Inc.
  • GlaxoSmithKline plc.
  • Bayer AG
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • McKesson Medical-Surgical Inc.
  • Novartis AG
  • Abbott

Get Sample Report Brochure Of Anti-Fungal Drugs Market at:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antifungal-drugs-market-101188

The global anti-fungal drugs market size is likely to reach USD 13.17 billion by 2027 on account of the increasing prevalence of skin infections worldwide. Mycosis or fungal infection is a skin disease caused by a group of spore-producing organisms living and feeding on the human skin. When untreated, they lead to skin issues such as rashes, athlete’s foot, yeast infection, ringworm, nail fungus, bumps, and others. According to a recently published report by Fortune Business Insights™ titled, “Anti-Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Others), and Regional Forecast, 2020-2027,” the market value was USD 10.24 billion in 2019, and will exhibit a CAGR of 3.3% between 2020 and 2027.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Growing Popularity of Electric Vehicles Worldwide to Restrict the Market

Various factors are responsible for the anti-fungal drugs market growth. These include the increasing number of bacterial skin infections and other skin issues. Besides this, a rise in the number of cancer cases and the growth of hematopoietic stem cell transplantation have led to the increasing incidence of nosocomial infections that will further propel the market in the years to follow.

On the contrary, a rise in the availability of generic drugs among other expensive drugs for treating fungal infections may pose a major hindrance to the overall market. This, coupled with the strict rules imposed by the government on patent expiry and use of counterfeit drugs are expected to hamper the market. Additionally, the use of adverse drugs may result in hypokalemia, bone marrow suppression, nephrotoxicity, and others, thus posing major challenges to the market in the coming years.

The global pandemic, COVID-19, has led to severe repercussion owing to its widespread effects across several economies. Several industries are facing unprecedented losses owing to the lockdown announced by several governments across the globe that has resulted in the complete shutdown of the businesses. The crippling economy, however, is being revived through collective efforts from the government as well as the industries and is expected to bounce back in the coming years.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Anti-Fungal Drugs Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Anti-Fungal Drugs Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Speak to Anti-Fungal Drugs Industry Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antifungal-drugs-market-101188

Competitive And Regional Analysis:

This report focuses on Anti-Fungal Drugs Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report.

North America to Hold Lion’s Share in the Market; Asia-Pacific to Follow

North America emerged dominant with a revenue of USD 4.61 billion earned in 2019. The growth of this region is attributed to a rise in the awareness about hygiene and the increasing adoption of advanced therapeutics for diagnostic purposes. This, coupled with the presence of better healthcare infrastructure and medical facilities are likely to aid in the expansion of the regional market in the coming years, thereby increasing the demand for anti-fungal drugs.

On the other side, Europe will rank second owing to the developing healthcare infrastructure and the increasing number of patients suffering from fungal infections. Furthermore, the market in Asia Pacific will emerge as the fastest-growing market on account of the rising research and development activities by major players, a surge in the number of hospital-oriented infections, and supportive government awareness programs about personal health and hygiene.

Anti-Fungal Drugs Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Browse complete report information at:

https://www.fortunebusinessinsights.com/industry-reports/antifungal-drugs-market-101188

Key questions answered in the report:

  • What are the opportunities & challenges for new entrants?
  • Who are the prominent vendors present in the global market?
  • Which segment would provide the most opportunity for market growth?
  • Where will the current developments take the industry in the long term?

Table of Content:

1 Anti-Fungal Drugs Market Overview

1.1 Anti-Fungal Drugs Product Overview

1.2 Anti-Fungal Drugs Market Segment by Type

1.3 Global Anti-Fungal Drugs Market Size by Type (2015-2026)

1.3.1 Anti-Fungal Drugs Global Market Size Overview by Type (2015-2026)

1.3.2 Global Anti-Fungal Drugs Historic Market Size Review by Type (2015-2021)

1.3.2.1 Anti-Fungal Drugs Sales Global Market Share Breakdown by Type (2015-2026)

1.3.2.2 Anti-Fungal Drugs Global Market Share Breakdown by Type (2015-2026)

1.3.2.3 Global Anti-Fungal Drugs Average Selling Price (ASP) by Type (2015-2026)

1.3.3 Anti-Fungal Drugs Market Size Forecast by Type (2021-2026)

1.3.3.1 Global Anti-Fungal Drugs Sales Market Share Breakdown by Application (2021-2026)

1.3.3.2 Global Anti-Fungal Drugs Revenue Market Share Breakdown by Application (2021-2026)

1.3.3.3 Global Anti-Fungal Drugs Average Selling Price (ASP) by Application (2021-2026)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Anti-Fungal Drugs Sales Breakdown by Type (2015-2026)

1.4.2 Europe Anti-Fungal Drugs Sales Breakdown by Type (2015-2026)

1.4.3 Asia-Pacific Anti-Fungal Drugs Sales Breakdown by Type (2015-2026)

1.4.4 Latin America Anti-Fungal Drugs Sales Breakdown by Type (2015-2026)

1.4.5 Middle East and Africa Anti-Fungal Drugs Sales Breakdown by Type (2015-2026)

2 Global Anti-Fungal Drugs Market Competition by Company

2.1 Global Top Players by Anti-Fungal Drugs Sales (2015-2021)

2.2 Global Top Players by Anti-Fungal Drugs Revenue (2015-2021)

2.3 Global Top Players Anti-Fungal Drugs Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Anti-Fungal Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Anti-Fungal Drugs Market Competitive Situation and Trends

2.5.1 Anti-Fungal Drugs Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Anti-Fungal Drugs Sales and Revenue in 2019

2.6 Global Anti-Fungal Drugs Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Fungal Drugs as of 2019)

2.7 Date of Key Company Enter into Anti-Fungal Drugs Market

2.8 Key Company Anti-Fungal Drugs Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Anti-Fungal Drugs Status and Outlook by Region (2015-2026)

3.1 Global Anti-Fungal Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2026

3.2 Global Anti-Fungal Drugs Market Size Market Share by Region (2015-2021)

3.2.1 Global Anti-Fungal Drugs Sales Market Share by Region (2015-2021)

3.2.2 Global Anti-Fungal Drugs Revenue Market Share by Region (2015-2021)

3.2.3 Global Anti-Fungal Drugs Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Anti-Fungal Drugs Market Size Market Share by Region (2021-2026)

3.3.1 Global Anti-Fungal Drugs Sales Market Share by Region (2021-2026)

3.3.2 Global Anti-Fungal Drugs Revenue Market Share by Region (2021-2026)

3.3.3 Global Anti-Fungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

3.4 North America Anti-Fungal Drugs Market Size By Growth (2015-2026)

3.4.1 North America Anti-Fungal Drugs Revenue By Growth (2015-2026)

3.4.2 North America Anti-Fungal Drugs Sales By Growth (2015-2026)

3.5 Asia-Pacific Anti-Fungal Drugs Market Size By Growth (2015-2026)

3.5.1 Asia-Pacific Anti-Fungal Drugs Revenue By Growth (2015-2026)

3.5.2 Asia-Pacific Anti-Fungal Drugs Sales By Growth (2015-2026)

3.6 Europe Anti-Fungal Drugs Market Size By Growth (2015-2026)

3.6.1 Europe Anti-Fungal Drugs Revenue By Growth (2015-2026)

3.6.2 Europe Anti-Fungal Drugs Sales By Growth (2015-2026)

3.7 Latin America Anti-Fungal Drugs Market Size By Growth (2015-2026)

3.7.1 Latin America Anti-Fungal Drugs Revenue By Growth (2015-2026)

3.7.2 Latin America Anti-Fungal Drugs Sales By Growth (2015-2026)

3.8 Middle East and Africa Anti-Fungal Drugs Market Size By Growth (2015-2026)

3.8.1 Middle East and Africa Anti-Fungal Drugs Revenue By Growth (2015-2026)

3.8.2 Middle East and Africa Anti-Fungal Drugs Sales By Growth (2015-2026)

4 Global Anti-Fungal Drugs by Application

4.1 Anti-Fungal Drugs Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Anti-Fungal Drugs Sales by Application: 2015 VS 2021 VS 2026

4.3 Global Anti-Fungal Drugs Historic Sales by Application (2015-2021)

4.4 Global Anti-Fungal Drugs Forecasted Sales by Application (2021-2026)

4.5 Key Regions Anti-Fungal Drugs Market Size by Application

4.5.1 North America Anti-Fungal Drugs by Application

4.5.2 Europe Anti-Fungal Drugs by Application

4.5.3 Asia-Pacific Anti-Fungal Drugs by Application

4.5.4 Latin America Anti-Fungal Drugs by Application

4.5.5 Middle East and Africa Anti-Fungal Drugs by Application

5 North America Anti-Fungal Drugs Market Size by Country (2015-2026)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Anti-Fungal Drugs Sales Market Share by Country (2015-2021)

5.1.2 North America Anti-Fungal Drugs Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2026)

5.2.1 North America Anti-Fungal Drugs Sales Market Share by Country (2021-2026)

5.2.2 North America Anti-Fungal Drugs Revenue Market Share by Country (2021-2026)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Anti-Fungal Drugs Market Size By Growth (2015-2026)

5.3.2 Canada Anti-Fungal Drugs Market Size By Growth (2015-2026)

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email